Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Morganroth

Showing results (1-10 of 214) with videos related to

Pageof 22
Sort By:
Comprehensive Therapy|May 1, 1975
Clinical echocardiographyJ Morganroth
JAMA|August 3, 1984
Premature ventricular complexes. Diagnosis and indications for therapyJ Morganroth
Cardiovascular Drugs and Therapy|February 1, 1992
Early and late proarrhythmia from antiarrhythmic drug therapyJ Morganroth
Annals of the New York Academy of Sciences|January 1, 1984
Computer recognition of cardiac arrhythmias and statistical approaches to arrhythmia analysisJ Morganroth
The American Journal of Cardiology|February 20, 1990
Dose effect of moricizine on suppression of ventricular arrhythmiasJ Morganroth
Ernst Schering Research Foundation Workshop|November 23, 2006
Evaluation of the effect on cardiac repolarization (QTc interval) of oncologic drugsJ Morganroth
The American Journal of Cardiology|April 30, 1987
Risk factors for the development of proarrhythmic eventsJ Morganroth
Annals of Internal Medicine|January 1, 1985
Ambulatory Holter electrocardiography: choice of technologies and clinical usesJ Morganroth
The American Journal of Cardiology|September 1, 1986
Intravenous atenolol for ventricular arrhythmiasJ Morganroth
Circulation|February 1, 1986
Ambulatory electrocardiographic monitoring in the evaluation of new antiarrhythmic drugsJ Morganroth
Pageof 22

Showing results (1-10 of 214) with videos related to

Sort By:
Pageof 22
Comprehensive Therapy|May 1, 1975
Clinical echocardiographyJ Morganroth
JAMA|August 3, 1984
Premature ventricular complexes. Diagnosis and indications for therapyJ Morganroth
Cardiovascular Drugs and Therapy|February 1, 1992
Early and late proarrhythmia from antiarrhythmic drug therapyJ Morganroth
Annals of the New York Academy of Sciences|January 1, 1984
Computer recognition of cardiac arrhythmias and statistical approaches to arrhythmia analysisJ Morganroth
The American Journal of Cardiology|February 20, 1990
Dose effect of moricizine on suppression of ventricular arrhythmiasJ Morganroth
Ernst Schering Research Foundation Workshop|November 23, 2006
Evaluation of the effect on cardiac repolarization (QTc interval) of oncologic drugsJ Morganroth
The American Journal of Cardiology|April 30, 1987
Risk factors for the development of proarrhythmic eventsJ Morganroth
Annals of Internal Medicine|January 1, 1985
Ambulatory Holter electrocardiography: choice of technologies and clinical usesJ Morganroth
The American Journal of Cardiology|September 1, 1986
Intravenous atenolol for ventricular arrhythmiasJ Morganroth
Circulation|February 1, 1986
Ambulatory electrocardiographic monitoring in the evaluation of new antiarrhythmic drugsJ Morganroth
Pageof 22